Medicare Enrolled
Dr. Steven Newman, MD
Medical Oncology · Naples, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Newman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Newman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Newman
Dr. Steven Newman is a medical oncology in Naples, FL, with 20 years in practice. Based on federal Medicare data, Dr. Newman performed 482,715 Medicare services across 8,773 unique beneficiaries.
Between the years covered by Open Payments, Dr. Newman received a total of $35,404 from 100 pharmaceutical and/or device companies across 1385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Newman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 1% volume in FL$ $35,404 industry payments
Medicare Practice Summary
Medicare Utilization ↗482,715
Medicare services
Top 1% in FL for medical oncology
8,773
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~24,136 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 128,520 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 85,020 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 50,800 | $43 | $137 |
| Anti-nausea injection (aprepitant) | 35,620 | $1 | $5 |
| Epoetin alfa injection (Procrit) for anemia | 23,670 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 22,200 | $18 | $51 |
| Paclitaxel chemotherapy injection | 15,956 | $0 | $2 |
| Oxaliplatin chemotherapy injection | 14,320 | $0 | $14 |
| Immune globulin infusion (Gammagard) | 11,796 | $36 | $108 |
| Injection, durvalumab, 10 mg | 11,028 | $62 | $191 |
| Azacitidine chemotherapy injection | 10,700 | $0 | $4 |
| Daratumumab injection (Darzalex) | 9,000 | $38 | $110 |
| Iron sucrose injection (Venofer) | 7,100 | $0 | $5 |
| Dexamethasone injection (steroid) | 6,436 | $0 | $3 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 6,289 | $23 | $185 |
| Complete blood count (CBC) with differential | 5,841 | $8 | $29 |
| Blood draw (venipuncture) | 5,468 | $8 | $9 |
| Injection, eflapegrastim-xnst, 0.1 mg | 5,148 | $26 | $116 |
| Office visit, established patient (30-39 min) | 3,713 | $98 | $339 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,610 | $1 | $28 |
| Injection, bortezomib, 0.1 mg | 3,605 | $4 | $113 |
| Drug injection, under skin or into muscle | 1,783 | $11 | $69 |
| Anti-nausea injection (ondansetron/Zofran) | 1,736 | $0 | $9 |
| Injection, octreotide, depot form for intramuscular injection, 1 mg | 1,430 | $161 | $515 |
| Injection of additional new drug or substance into vein | 1,396 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 1,270 | $101 | $378 |
| Injection, carboplatin, 50 mg | 854 | $2 | $41 |
| Injection, fluorouracil, 500 mg | 633 | $2 | $7 |
| Injection, diphenhydramine hcl, up to 50 mg | 544 | $1 | $3 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 540 | $50 | $189 |
| Injection, leucovorin calcium, per 50 mg | 522 | $3 | $12 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 509 | $23 | $84 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 431 | $18 | $59 |
| Administration of chemotherapy into vein, each additional hour | 389 | $22 | $79 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 372 | $87 | $642 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 364 | $1 | $6 |
| Infusion, normal saline solution , 1000 cc | 302 | $2 | $7 |
| Injection, cisplatin, powder or solution, 10 mg | 283 | $2 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 275 | $16 | $56 |
| Administration of additional new drug or substance into vein, 1 hour or less | 254 | $51 | $178 |
| Infusion into a vein for hydration, each additional hour | 243 | $10 | $42 |
| Infusion into a vein for hydration, 31-60 minutes | 217 | $26 | $156 |
| Injection of drug or substance into vein | 198 | $29 | $156 |
| New patient office visit (45-59 min) | 193 | $124 | $453 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 189 | $3 | $11 |
| Automated urinalysis | 187 | $2 | $8 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 168 | $58 | $206 |
| Red blood count, automated test | 151 | $4 | $10 |
| Office visit, established patient (20-29 min) | 149 | $70 | $239 |
| Injection, magnesium sulfate, per 500 mg | 144 | $1 | $2 |
| Injection, zoledronic acid, 1 mg | 141 | $7 | $69 |
| Administration of additional new drug or substance into vein using push technique | 127 | $44 | $170 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 111 | $129 | $562 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 94 | $4 | $15 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 88 | $1 | $7 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 81 | $23 | $89 |
| Drawing of blood for a medical problem | 81 | $69 | $277 |
| Initial hospital admission, high complexity | 81 | $142 | $556 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 78 | $136 | $637 |
| New patient office visit (30-44 min) | 59 | $88 | $298 |
| Initial hospital admission, moderate complexity | 49 | $107 | $377 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 47 | $16 | $56 |
| Office visit, established patient, complex (40-54 min) | 43 | $145 | $474 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 36 | $127 | $467 |
| Administration of chemotherapy into vein using push technique | 33 | $81 | $303 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
29.5% high complexity
66.9% medium
3.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$35,404
Total received (2018-2024)
Avg $5,058/year across 7 years
Top 16% in FL for medical oncology
100
Companies
1,385
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,674 (69.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,705 (27.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,025 (2.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$4,580
2023$4,540
2022$4,576
2021$4,113
2020$3,078
2019$3,095
2018$11,422
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Alexion Pharmaceuticals, Inc.
$8,017
Janssen Pharmaceuticals, Inc
$2,726
Novartis Pharmaceuticals Corporation
$2,037
E.R. Squibb & Sons, L.L.C.
$1,668
Celgene Corporation
$1,290
AstraZeneca Pharmaceuticals LP
$1,284
PFIZER INC.
$1,245
Janssen Biotech, Inc.
$1,005
Genentech USA, Inc.
$981
GENZYME CORPORATION
$881
Merck Sharp & Dohme Corporation
$880
Merck Sharp & Dohme LLC
$826
Incyte Corporation
$748
Gilead Sciences, Inc.
$687
Seagen Inc.
$645
Regeneron Healthcare Solutions, Inc.
$631
Amgen Inc.
$553
Lilly USA, LLC
$537
GlaxoSmithKline, LLC.
$532
BeiGene USA, Inc.
$463
Astellas Pharma US Inc
$427
Eisai Inc.
$368
Alnylam Pharmaceuticals Inc.
$333
Bayer Healthcare Pharmaceuticals Inc.
$317
Daiichi Sankyo Inc.
$311
Foundation Medicine, Inc.
$310
EMD Serono, Inc.
$308
Bayer HealthCare Pharmaceuticals Inc.
$276
ARRAY BIOPHARMA INC
$272
Kite Pharma, Inc.
$246
Puma Biotechnology, Inc.
$220
Takeda Pharmaceuticals U.S.A., Inc.
$203
Sirtex Medical Inc
$188
SANOFI-AVENTIS U.S. LLC
$186
Apellis Pharmaceuticals, Inc.
$184
Myriad Genetic Laboratories, Inc.
$168
ABBVIE INC.
$163
MOTIVA USA, LLC
$148
Pharmacyclics LLC, an AbbVie Company
$142
Deciphera Pharmaceuticals Inc.
$134
EISAI INC.
$133
Agios Pharmaceuticals, Inc.
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$129
MorphoSys, US Inc.
$114
Exelixis Inc.
$109
TESARO, Inc.
$104
CTI BioPharma Corp.
$102
Pharmacyclics LLC, An AbbVie Company
$100
SEAGEN INC.
$100
Myovant Sciences Inc.
$100
PUMA BIOTECHNOLOGY, INC.
$94
Dova Pharmaceuticals
$88
SOBI, INC
$84
PharmaEssentia USA Corporation
$81
Epizyme, Inc.,
$79
Kyowa Kirin, Inc.
$61
Lexicon Pharmaceuticals, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$59
ADC Therapeutics America, Inc.
$58
Sobi, Inc
$53
AbbVie, Inc.
$53
Stemline Therapeutics Inc.
$52
NanoString Technologies, Inc.
$47
Jazz Pharmaceuticals Inc.
$44
Rigel Pharmaceuticals, Inc.
$44
Acrotech Biopharma LLC
$43
Secura Bio, Inc.
$40
TerSera Therapeutics LLC
$39
SERVIER PHARMACEUTICALS LLC
$38
AbbVie Inc.
$36
TAIHO ONCOLOGY, INC.
$35
Karyopharm Therapeutics Inc.
$35
Acrotech Biopharma Inc.
$35
AMAG Pharmaceuticals, Inc.
$34
Ipsen Biopharmaceuticals, Inc
$32
Acceleron Pharma, Inc.
$30
Janssen Scientific Affairs, LLC
$24
Novo Nordisk Inc
$24
Coherus Biosciences Inc.
$22
Pharmacosmos Therapeutics Inc.
$20
G1 Therapeutics, Inc.
$20
Taiho Oncology, Inc.
$20
Partner Therapeutics, Inc.
$19
Dendreon Pharmaceuticals LLC
$19
Teva Pharmaceuticals USA, Inc.
$18
Horizon Pharma plc
$18
Octapharma USA, Inc.
$17
INSYS Therapeutics Inc
$16
Aurobindo Pharma USA, Inc.
$15
AVEO Pharmaceuticals, Inc.
$15
Seattle Genetics, Inc.
$15
Heron Therapeutics, Inc.
$15
Emmaus Medical, Inc.
$14
Clovis Oncology, Inc.
$14
Mirati Therapeutics, Inc.
$13
Aveo Pharmaceuticals, Inc.
$12
Verastem, Inc.
$12
EUSA Pharma (US) LLC
$12
Shire North American Group Inc
$11
Veracyte, Inc.
$2
Top 3 companies account for 36.1% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Beleodaq · CABLIVI · CALQUENCE · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERLEADA · EVENITY · Empaveli · Endari · Enhertu · Erleada · FARYDAK · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · HYQVIA · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · Inrebic · JADENU · JAKAFI · JAYPIRCA · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · KRYSTEXXA · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · Mavenclad · Motiva Implant Matrix · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · Ozempic · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (70%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $7 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
12
Per 100K population
3.1
County median income
$86,173
Nearest hospital
NAPLES COMMUNITY HOSPITAL
4.2 mi
4.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Newman is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (low-engagement, top 16%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Newman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Newman performed 128,520 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Newman receive payments from pharmaceutical companies?
Yes. Dr. Newman received a total of $35,404 from 100 companies across 1,385 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Newman's costs compare to other medical oncologys in Naples?
Dr. Newman's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Newman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Naples
Browse medical oncologys in Naples ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc..
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology